Fierce Healthcare October 10, 2023
Paige Minemyer

LAS VEGAS—Medicare Advantage (MA) has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder.

But can the faults in MA be solved, or is the answer to scrap the program entirely? That topic was up for debate Monday during HLTH, where SCAN Group CEO Sachin Jain, M.D., and consultant Rick Gilfillan, M.D., sat down on the main stage to discuss the Wild West of MA.

Both Jain and Gilfillan have experience at the Centers for Medicare & Medicaid Services as well as in both the payer and provider worlds. Gilfillan most recently served as CEO of Trinity Health, departing the health system in 2019.

Jain said that while there...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Insurance, Medicare Advantage, Trends
CMS Plans 4.3% Medicare Advantage Payment Increase for 2026
Growth in Medicare Advantage Raises Concerns
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
CMS proposes $21B payment increase for Medicare Advantage in 2026: 10 notes
Medicare Advantage leads to lower cancer drug costs in colorectal cancer

Share This Article